BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29804151)

  • 41. Novel 6-Phenylnicotinohydrazide Derivatives: Design, Synthesis and Biological Evaluation as a Novel Class of Antitubercular and Antimicrobial Agents.
    Soliman DH; Eldehna WM; Ghabbour HA; Kabil MM; Abdel-Aziz MM; Abdel-Aziz HA
    Biol Pharm Bull; 2017; 40(11):1883-1893. PubMed ID: 29093335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and Antimicrobial, Anticancer and Anti-Oxidant Activities of Novel 2,3-Dihydropyrido[2,3-d]pyrimidine-4-one and Pyrrolo[2,1-b][1,3]benzothiazole Derivatives via Microwave-Assisted Synthesis.
    Al-Mutairi AA; Hafez HN; El-Gazzar ABA; Mohamed MYA
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent quorum sensing in
    Srinivasarao S; Nandikolla A; Nizalapur S; Yu TT; Pulya S; Ghosh B; Murugesan S; Kumar N; Chandra Sekhar KVG
    RSC Adv; 2019 Sep; 9(50):29273-29292. PubMed ID: 35528444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indolylmethylene benzo[h]thiazolo[2,3-b]quinazolinones: synthesis, characterization and evaluation of anticancer and antimicrobial activities.
    Gali R; Banothu J; Porika M; Velpula R; Hnamte S; Bavantula R; Abbagani S; Busi S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4239-42. PubMed ID: 25096298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
    Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3.
    Taherian E; Khodarahmi G; Khajouei MR; Hassanzadeh F; Dana N
    Res Pharm Sci; 2019 Jun; 14(3):247-254. PubMed ID: 31160902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.
    Abd El-All AS; Magd-El-Din AA; Ragab FA; ElHefnawi M; Abdalla MM; Galal SA; El-Rashedy AA
    Arch Pharm (Weinheim); 2015 Jul; 348(7):475-86. PubMed ID: 25900113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, Characterization, and Antimicrobial Activity Screening of Some Novel 3-(2-(3-(Substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline Derivatives as Potential Antimycobacterial Agents.
    Shinde A; Ugale SR; Nandurkar Y; Modak M; Chavan AP; Mhaske PC
    ACS Omega; 2022 Dec; 7(50):47096-47107. PubMed ID: 36570236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
    Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.
    Jadhav GR; Shaikh MU; Kale RP; Shiradkar MR; Gill CH
    Eur J Med Chem; 2009 Jul; 44(7):2930-5. PubMed ID: 19150154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis, Characterization, Antitubercular and Anti-Inflammatory Activity of New Pyrazolo[3,4-d]Pyrimidines.
    Kulkarni R; Kompalli K; Gaddam N; Mangannavar CV; Darna B; Garlapati A; Kumar D; Machha B
    Comb Chem High Throughput Screen; 2021; 24(8):1300-1308. PubMed ID: 32957875
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Kumar P; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Majeed ABA; De Clercq E
    Monatsh Chem; 2013; 144(6):825-849. PubMed ID: 32214480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
    Pathak RB; Chovatia PT; Parekh HH
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
    Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1,3-dione derivatives.
    Ahmed HE; Abdel-Salam HA; Shaker MA
    Bioorg Chem; 2016 Jun; 66():1-11. PubMed ID: 26986635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, Characterization, Anticancer and Antibacterial Activity of Some Novel Pyrano[2,3-d]pyrimidinone Carbonitrile Derivatives.
    Aremu OS; Gopaul K; Kadam P; Singh M; Mocktar C; Singh P; Koorbanally NA
    Anticancer Agents Med Chem; 2017; 17(5):719-725. PubMed ID: 27528181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benzoxazole derivatives: design, synthesis and biological evaluation.
    Kakkar S; Tahlan S; Lim SM; Ramasamy K; Mani V; Shah SAA; Narasimhan B
    Chem Cent J; 2018 Aug; 12(1):92. PubMed ID: 30101384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors.
    Abdelsalam EA; Zaghary WA; Amin KM; Abou Taleb NA; Mekawey AAI; Eldehna WM; Abdel-Aziz HA; Hammad SF
    Bioorg Chem; 2019 Aug; 89():102985. PubMed ID: 31121559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.